This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 1999 Feb 6;353(9151):423-4.

doi: 10.1016/S0140-6736(98)00362-6.

New antithrombotic treatment in unstable coronary syndrome--for whom?

Affiliations

PMID: 9989707
DOI: 10.1016/S0140-6736(98)00362-6

Comment

New antithrombotic treatment in unstable coronary syndrome--for whom?

L Wallentin. Lancet. 1999.

. 1999 Feb 6;353(9151):423-4.

doi: 10.1016/S0140-6736(98)00362-6.

Author

Affiliation

¹ Department of Cardiology, Cardiothoracic Centre, University Hospital, Uppsala, Sweden.

PMID: 9989707
DOI: 10.1016/S0140-6736(98)00362-6

No abstract available

PubMed Disclaimer

Comment on

Effects of recombinant hirudin (lepirudin) compared with heparin on death, myocardial infarction, refractory angina, and revascularisation procedures in patients with acute myocardial ischaemia without ST elevation: a randomised trial. Organisation to Assess Strategies for Ischemic Syndromes (OASIS-2) Investigators.
[No authors listed] [No authors listed] Lancet. 1999 Feb 6;353(9151):429-38. Lancet. 1999. PMID: 9989712 Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information